Enhanced survival and therapeutic choices for men with prostate cancer mandate the evaluation of the "quality of survival".
An exciting series of local, national and international health outcome improvement initiatives offer the enticing prospect of assessing and improving this.
Glaser AW, Corner JL. Are you the author?
Leeds Teaching Hospitals NHS Trust, Leeds Institute of Cancer and Pathology, Leeds, UK; Faculty of Health Sciences, Southampton University, Southampton, UK; Macmillan Cancer Support, London, UK.
Reference: Eur Urol. 2014 Nov 10. pii: S0302-2838(14)01037-9.